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To ensure the B cell differentiation stage specificity of the intronic EA element and of the locus control region (LCR) that lies downstream
of the IgH chain locus, we generated transgenic mice harboring a VH promoter-GFP reporter gene linked to the 3VLCR region and the EA
element. By flow cytometry, GFP+ lymphocytes were observed amongst pro-B cells (B220+CD43+CD117+) and at all stages of
differentiation up to mature B cells (B220+IgM+IgD+). Expression was strictly confined to cells committed to the B lymphocyte lineage as
judged by the lack of GFP+Thy1,2+ cells (T lymphocytes) and GFP+B220CD117+CD43+ cells (uncommitted lymphohematopoietic
progenitors). Therefore, the EA-GFP-3VLCR transgene is not expressed by hematopoietic stem cells, begins its expression in pro-B cells and is
specifically active at all stages of B cell maturation. The combination of 3Vand 5VIgH regulatory elements thus appears as a potentially useful
cassette in transgenes that require a stringent and early B lineage-specific expression.
D 2003 Elsevier B.V. All rights reserved.Keywords: B lymphocyte; Transgenic; Gene regulation; EA; 3VLCR1. Introduction
A complex interplay of multiple regulatory elements is
responsible for tissue-specific and stage-specific regulation
of both transcription and rearrangements of the IgH chain
locus. Several events such as the germline transcription of
the CA region and the initiation of VDJ rearrangements are
regulated by upstream elements including the VH promoter
and the EA intronic enhancer [1]. In addition, four lym-
phoid-specific transcriptional enhancers (namely hs3a,
hs1,2, hs3b and hs4) have been located in a 3V regulatory
region downstream the locus. It has been suggested that the
latter altogether act as a locus control region (LCR). The
presence of three of these elements (hs1,2, hs3b and hs4)
confers a position-independent and a copy-dependent ex-
pression to a c-myc transgene transfected in a plasmacy-0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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E-mail address: laurence.guglielmi@unilim.fr (L. Guglielmi).toma cell line [2]. Confirming these results, Chauveau et al.
[3] reported that transgenic mice bearing a h-globin report-
er gene linked to the 3VLCR displayed a high level,
position-independent and B cell-specific expression. Our
knowledge of the role of these 3Venhancers mostly derives
from in vitro studies [4]. Thus, transient transfection experi-
ments and reporter gene assays revealed that the four 3V
enhancers are rather weak by themselves but that their
combination display a strong transcriptional synergy espe-
cially when the normal palindromic arrangement is
respected [4–6]. All these studies provided important
information about synergies between enhancers and sug-
gested a B cell-restricted activity of the 3V IgH elements.
However, they analyzed only bulk of transfected cells or
whole organs and did not allow to definitely assess at what
stage of B cell development and in which percentage of
cells of the B or T lineage transgenes were expressed. The
EA intronic enhancer has been already used in DNA
constructs in order to target expression to the B cell lineage.
However, EA-driven transgenes are often transcribed at high
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addition to this poor B cell specificity, EA-driven reporter
genes that are efficiently expressed in transfected cell lines
may sometimes be completely silenced in transgenic ani-
mals [10]. It was thus interesting to check if a mini-locus
associating both EA and the 3Velements would follow more
closely the expression pattern of the endogenous locus, a
result that could be of interest in order to direct the early
and B lineage-specific expression of therapeutic gene con-
structs for gene therapy applications. Moreover, until now,
little was known about the kinetics of expression of the 3V
IgH enhancers during the B cell differentiation in vivo.
Although endogenous 3Venhancers mostly appear as DN-
Ase I hypersensitive in terminally differentiated B cells,
they proved to be able to strongly synergize with EA upon
transfection in a pre-B cell line [5]. We therefore undertook
the generation of transgenic mice harboring a VH promoter-
green fluorescent protein (GFP) reporter gene linked to all
four 3VIgH enhancers in association with the EA element.
GFP is a 238 amino acid protein that requires no host
cofactor and emits a green fluorescence (kmax 507 nm) in
living cells transfected with GFP cDNA after light stimu-
lation (kmax 488 nm) [11]. Taking advantage of the spon-
taneous GFP fluorescence, it was monitored that the EA-
GFP-3VLCR transgene yielded both an early and strong
expression from pro-B cells to mature B cells and a
stringent repression in non-B cells. Therefore, the combi-
nation of 3Vand 5VIgH regulatory elements may constitute aFig. 1. (A) Schematic diagrams of the murine IgH locus and of the EA-GFP-3VLC
cells (unshaded area) and transfected cells (shaded area) were analyzed for GFP fl
are shown.potentially useful cassette in transgenes for which a strin-
gent and early B lineage-specific expression is required.2. Materials and methods
2.1. Vector construction
A schematic representation of the EA-GFP-3VLCR trans-
gene is presented in Fig. 1A. It was built to mimic the
endogenous configuration. The pVH promoter is a 0.2-kb
HindIII fragment derived from a rearranged murine VH
segment. The hs1,2 is a 0.6-kb StuI–EcoRV murine ge-
nomic fragment [12]. Two 2.1-kb EcoRI–HindIII genomic
fragments, corresponding to hs3a and hs3b, were cloned
with symmetric orientations on both sides of the hs1,2
enhancer, according to their endogenous arrangement [13].
hs4 is a 1.38-kb PstI–HindIII genomic fragment [2]. The EA
enhancer, a 1-kb XbaI fragment [14], was inserted upstream
of the pVH promoter. The GFP coding sequence was a
NotI–SalI fragment excised from the pEGFP-1 vector
(Clontech Laboratories, Palo Alto, CA).
2.2. Cell line transfection
18–81 cells (a murine pre-B cell line) and A20 cells (a
murine IgM+ B cell line) were obtained from ATCC (Rock-
ville, MD). They were cultured in RPMI 1640 supplementedR transgene. (B) GFP expression in transfected B cell lines. Untransfected
uorescence. Results from a representative A20 and 18–81 transfected clone
Fig. 2. Northern blot analysis of GFP transcripts. Total RNA from spleen
and thymus of EA-GFP-3VLCR transgenic and control mice were hybridized
with a GFP probe. In parallel, n and h-actin transcripts were monitored as
internal controls.
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ml streptomycin, 100 U/ml penicillin, and 1 AM h-mercap-
toethanol. Fifteen micrograms of linearized vector were co-
transfected with a DNA fragment containing the neomycinFig. 3. GFP fluorescence (A) labelled splenocytes in the spleen of EA-GFP-3VLCR tra
(B) and GFP transcripts (C) confirms the co-localisation of the labelling in both smalresistance gene in a molar ratio of 10:1. Cells (20 106)
were transfected by electroporation at 250 Vand 960 AF and
then distributed on five 96-well culture plates in growth
medium supplemented with 600 Ag/ml geneticin (Sigma,
France). After 2–3 weeks, resistant clones were transferred
to 24-well culture plates.
2.3. Generation of transgenic mice
Cells of the embryonic stem (ES) cell line E14 were co-
transfected by electroporation with the linearized vector and
the neomycin-resistant gene (molar ratio 10:1) and selected
using geneticin (330 Ag/ml) [15]. Southern blot analysis
with a GFP probe identified GFP-positive clones. Two ES
clones were injected into C57BL/6 blastocysts, and the
resulting male chimeras were mated with C57BL/6 females.
Germline transmission was assessed by coat colour, and the
presence of the transgene was checked by Southern blot.
2.4. Southern blot analysis
Genomic DNA was extracted from cell lines, ES clones
and mice organs with the phenol/chloroform method. Tennsgenic mice. The same section treated for the detection of GFP fluorescence
l groups of splenocytes (arrow) and in B cell follicles (inside the dashed line).
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restriction products were loaded on 0.7% agarose gels,
transferred on nylon sheets (Amersham, Buckinghamshire,
UK) and hybridized with a DNA GFP probe (a 0.7-kb
PCR fragment of the GFP gene). Blots were autoradio-
graphed or analyzed on an Instant-Imager (Packard, CT) in
order to estimate the transgene copy number in cell lines
and transgenic mice.Fig. 4. Expression of GFP in bone marrow and spleen of transgenic mice. Con
were performed: the whole population of bone marrow cells and splenocytes we
on the FITC band pass filter) cells and analyzed with anti-B220 (PC5-labelling),
labelling) fluorescent antibodies. GFP+ splenocytes were analyzed with anti
fluorescent antibodies.2.5. Generation of RAG-1/ –ElGFP-3VLCR transgenic
mice
EA-GFP-3VLCR transgenic mice were mated with
recombinase activating gene-1 (RAG-1 / ) knock-out
mice [16]. F1 heterozygotes were backcrossed and South-
ern blot testing allowed the derivation of homozygous
lines. Probe used for RAG-1 /  mice was a 0.4-kb
hysica Acta 1642 (2003) 181–190trol experiments using PC5- or PE-labelled isotype irrelevant antibodies
re gated and analyzed. Bone marrow cells were gated on GFP+ (measured
anti-CD19 (PE-labelling), anti-CD43 (PE-labelling) and anti-CD117 (PE-
-B220, anti-CD19, anti-IgM (PE-labelling) and anti-IgD (PE-labelling)
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primer 5V-AGATCTTGATGACTACCTG-3V; reverse primer
5V-ATCTATATTTGAACTTGGTG-3V).
2.6. Northern blot analysis
Total RNA was prepared from spleen, thymus and liver
by homogenization of cells in Tripure (Roche, Germany).
Northern blotting was carried out after electrophoresis of 10
Ag of total RNA on a 1% agarose denaturing gel, followed
by transfer on nylon sheets. Probes used for hybridization
were the following: for n transcripts, a 2-kb AfIII genomic
fragment containing the mouse Cn gene; for GFP, a 0.7-kb
PCR fragment of the GFP gene; for h-actin, a 0.35-kb PCR
fragment of the h-actin gene. Blots were processed as
described above.
2.7. Flow cytometric analysis
Single-cell suspensions from fresh organs (thymus,
spleen, liver, bone marrow) were washed in PBS with 1%
BSA and labelled (5 105 cells per assay) with variousFig. 5. Expression of the EA-GFP-3VLCR transgene in RAG-1 /  mice. Bone marr
anti-CD25 (PE-labelling), anti-CD43, anti-CD117 and anti-IgM fluorescent antibo
controls (not shown).antibodies (Southern Biotechnologies, Birmingham, AL):
anti-B220 conjugated with SpectralRed (PC5), anti-CD19,
anti-CD25, anti-CD43, anti-CD117, anti-IgM and anti-IgD
conjugated with phycoerythrin (PE). Control experiments
included irrelevant isotype-matched antibodies conjugated
with PC5 or PE. The emitted fluorescence of GFP was
measured at 530 nm (fluorescein isothiocyanate (FITC)
band pass filter). Cells were analyzed on a Coulter XL
apparatus (Beckman Coulter, Fullerton, CA). Clones from
transfected B cell lines were directly submitted to flow
cytometry analysis.
2.8. In situ hybridization
The GFP gene was ligated into pGEM-T Easy Vector
(Promega, Madison, WI). The RNA probe was synthesized
with 1 Ag linearized plasmid and labelled with DIG-11-UTP
incorporated with SP6 RNA Polymerase (DIG RNA Label-
ling Kit, Boehringer Mannheim, Germany). Tissues were
quickly frozen at  80 jC until used. Cryosections were cut
(12 Am) and collected onto Superfrost/Plus slides (Polylabo,
Strasbourg, France). Sections were air-dried and then storedow cells were gated on GFP+ cells and analyzed with anti-B220, anti-CD19,
dies. Similar results to those of Fig. 4 were obtained from isotype-matched
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fixed for 8 min in freshly prepared 4% paraformaldehyde in
PBS pH 7.5. Pre-hybridization, hybridization, washing and
immunological detection of the hybrids were performed as
previously described [17,18]. Hybridization was visualized
using 4-nitroblue tetrazolium chloride and 5-bromo-4-
chloro-3 indolyl phosphate (NBT/BCIP/Boehringer) that
gives a blue precipitate and mounted using ‘‘immu-mount’’
(Shandon, USA). To improve the discrimination of the
labelled cells, a filter was used giving a brownish colour of
the indigo staining of the hybridizing cells.
2.9. Methylation assay
Genomic DNA (10 Ag) from spleen, liver and thymus
was digested with HpaII or MspI as previously reported
[10]. These enzymes are isoschizomers that cleave the DNA
motif CCGG. MspI can cleave DNA even when the 3VC
residue is 5V-methylcytosine while HpaII does not. Southern
blotting was carried out by migrating digested DNA on a
0.7% agarose gel, followed by transfer on nylon sheets, and
hybridization with a GFP probe. In another set of experi-
ments, bone marrow cells and splenocytes were incubated
with anti-B220 PC5-labelled antibodies. GFP+B220+ cellsFig. 6. Kinetics of GFP expression in transfected B cell lines and transgenic anim
Bone marrow cells were analyzed directly (upper panel) or after labelling with anand GFPB220+ cells were then sorted by FACS to obtain
genomic DNA for methylation assays.
2.10. In vitro and in vivo 5-azadeoxycytidine (5-azadC)
treatments
In the first set of experiments, splenocytes (1106 cells)
from 6-week-old mice were cultured (day 0) with LPS (20
Ag/ml) in RPMI 1640 supplemented with 10% FCS and
antibiotics. At day 1, 5-azadC was added to 0.1 AM and
cells were assayed for GFP fluorescence at day 4. In another
set of experiments, mice received a subcutaneous injection
of 5-azadC (70 Ag) and were subsequently analyzed at day 7
for GFP expression in bone marrow and spleen by flow
cytometry.3. Results
3.1. Expression of the El-GFP-3VLCR transgene in stably
transfected cells
The EA-GFP-3VLCR transgene was tested in cell lines
representative of pre-B cells (the 18–81 cell line) andals. (A) Results from a representative A20 transfected clone are shown. (B)
ti-B220-PC5 fluorescent antibodies (lower panel).
Fig. 7. Assessment of transgene methylation with the MspI –HpaII assay.
(A) DNAwas extracted from the spleen of 7-day, 3-week and 4-month-old
mice and submitted to the MspI –HpaII assay. (B) GFP+B220+ and
GFPB220+ bone marrow cells and splenocytes were purified by FACS
from a 1-week-old mouse to extract genomic DNA for the MspI –HpaII
assay.
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1B, GFP+ clones were readily obtained from both cell lines.
Expression efficiency (number of GFP+ clones assessed by
flow cytometry versus number of GFP+ clones assessed by
Southern blot) of the EA-GFP-3VLCR transgene was similar
in 18–81 cells (96%; 27/28) and A20 cells (78%; 18/23).
The high proportion of positive clones in both cell lines
strongly argued for an integration site-independent expres-
sion of the construct. Densitometry analysis of Southern blot
documented no copy number-dependent expression for the
EA-GFP-3VLCR transgene (data not shown).
3.2. Generation of transgenic mice
E14 ES cells were transfected with the EA-GFP-3VLCR
transgene in order to obtain ES clones. In contrast to A20 cells
and 18–81 cells, transfected ES cells were negative for GFP
expression (0/21). Two different ES clones were injected into
C57BL/6 blastocysts, which were implanted into foster
mothers to derive somatic chimeras. Chimeras were bred
with C57BL/6 animals to obtain F1 mice carrying the trans-
gene. Two independent founder lines were established. After
Southern blotting and hybridization with a GFP probe, the
estimated number of transgene copies was 6 and 10.
3.3. Expression of GFP mRNA by transgenic mice
To assess whether the EA-GFP-3VLCR transgene was
expressed in a tissue-specific manner, RNA was prepared
from spleen, thymus and liver of transgenic mice and
analyzed by Northern blot. High levels of GFP transcripts
were observed in the spleen of transgenic lines (Fig. 2).
GFP transcripts were not detected in their thymus (Fig. 2)
and liver (data not shown). The two founder lines gave
similar results. The cellular localisation of GFP transcript
in the spleen of transgenic mice was analyzed by in situ
hybridization experiments. As shown in Fig. 3A, GFP+
cells were found in B cell follicles of the spleen. Cyto-
fluorescence and in situ hybridization experiments con-
firmed the co-localisation of GFP mRNA and GFP protein
(Fig. 3B and C).
3.4. Expression of GFP during B cell development
To examine the B-specific expression of the GFP trans-
gene in EA-GFP-3VLCR mice, cells were recovered from
thymus, spleen and bone marrow and submitted to flow
cytometry analysis. Femoral bone marrow cells and spleno-
cytes expressed the GFP protein (Fig. 4). In contrast, GFP
expression was undetectable in thymus (data not shown). To
follow the GFP expression along the B cell development,
femoral bone marrow cells and splenocytes were labelled
with various antibodies. In bone marrow, all GFP+ cells
were B220+ and the vast majority were CD19+, indicating a
B lymphocyte-specific expression of our construct. The
presence of GFP+B220+CD19 cells indicates that GFPexpression begins before the appearance of the CD19
marker. Early expression was also indicated by the presence
of GFP+B220+CD117+ and GFP+B200+CD43+ cells in bone
marrow (Fig. 4). Therefore, transgene expression starts at
the early pro-B cell stage. On the other hand, GFP+
splenocytes were B220+CD19+IgM+IgD+ showing trans-
gene expression in mature B cells (Fig. 4). Thus, these
results highlighted a continuous GFP expression from pro-B
(B220+CD19CD43+CD117+) to mature B cells. The trans-
gene expression was strictly confined to cells committed to
the B lymphocyte lineage as judged by the lack of
GFP+B220CD117+CD43+ cells in bone marrow (Fig. 4)
and GFP+Thy1,2+ T cells in spleen and thymus (data not
shown). The two founder lines gave similar results.
3.5. Expression of the El-GFP-3VLCR transgene in
RAG-1/ mice
To identify more precisely the first B cell maturation stage
showing expression of the EA-GFP-3VLCR transgene, ani-
mals were mated with homozygous RAG-1 deficient mice
which are characterized by a B cell development blockade at
the pro-B cell stage. Inactivation of RAG-1 gene results in
the inability of developing lymphocytes to initiate D to JH
recombination. Offspring were intercrossed to produce ho-
mozygous RAG-1 / EA-GFP-3VLCR transgenic mice. The
transgene expression in RAG-1 / mice was strictly con-
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judged by the lack of GFP expression among B220 cells.
The main phenotype of bone marrow GFP+ cells in such
mice was B220+CD19+CD117+CD43+CD25IgM (Fig. 5),
corresponding to accumulated pro-B cells blocked in their
progression to the pre-B cell stage.
3.6. Extinction of the El-GFP-LCR transgene through DNA
methylation
Kinetic experiments indicated that the GFP fluorescence
remained stable in A20 (Fig. 6A) and 18–81 cells (data not
shown) for at least 4 months. In contrast, a rapid extinction
of the GFP expression was found both in bone marrow (Fig.
6B) and in spleen (data not shown) of EA-GFP-LCR trans-
genic mice. The two founder lines gave similar results (data
not shown). Among B220+ cells, the percentage (mean -
F S.E. of four animals) of GFP+ femoral bone marrow cells
was 57.4F 11.1, 35.4F 7.0, 7.4F 1.5 and 0 after 1, 2, 4 and
6 weeks of age, respectively. Among B220+ splenocytes, the
percentage of GFP+ splenocytes was 54.1F10.4, 48.0F
10.5, 10.2F 1.5 and 0 after 1, 2, 4 and 6 weeks of age,
respectively. One explanation might have been the deletion
of the GFP transgene but Southern blot analysis excludedFig. 8. Effects of 5-azadC on GFP transcription. (A) Splenocytes from a 6-week ag
5-azadC (shaded area) or not (unshaded area). 5-azadC treatment rescued the expr
bone marrow cells of a 6-week aged transgenic mouse either uninjected or injectthis possibility (data not shown). Another hypothesis might
involve a loss of transcriptional activity of the GFP trans-
gene, related to DNA methylation. In support of this hy-
pothesis, experiments showed methylation of the GFP
transgene in the spleen during the first month after birth
(Fig. 7A). This phenomenon was not tissue-specific since it
was also observed in thymus and liver (data not shown), two
organs that did not express the GFP protein. As reported
above, GFP expression was only found in 50% of B220+
splenocytes and bone marrow cells of 1-week-old mice. To
ensure whether this result might be due to the methylation
process, GFP+B220+ and GFPB220+ femoral cells and
splenocytes were purified by FACS in order to extract
genomic DNA. As reported in Fig. 7B, the MspI–HpaII
assay indicated that, in 1-week-old mice, the GFP transgene
was more heavily methylated in GFPB220+ cells than in
GFP+B220+ cells. In order to confirm the role of methyl-
ation, LPS-stimulated splenocytes of 6-week-old mice, that
no longer express the GFP transgene, were cultured with the
drug 5-azadC, a cytidine analog that inhibits methylation
when incorporated into DNA. As reported in Fig. 8A,
treatment with 5-azadC produced a significant reactivation
of the GFP expression in splenocytes. Finally, it was
determined that demethylation of the transgene in vivoed transgenic mouse were induced to proliferate with LPS and treated with
ession of GFP silenced by methylation. (B) Flow cytometry analysis of the
ed with 5-azadC and analyzed 1 week later for GFP expression.
L. Guglielmi et al. / Biochimica et Biophysica Acta 1642 (2003) 181–190 189would reactivate the GFP expression, since 6-week-old 5-
azadC-treated animals, but not untreated littermates, had
GFP+B220+ bone marrow cells (Fig. 8B).4. Discussion
Previous studies of 3VIgH enhancers used the CAT gene
or a truncated h-globin gene as reporters in transfected cells
and in transgenic mice, respectively [3,5]. Due to the
reporter genes used, these studies could provide no indica-
tion about the B cell lineage developmental stage-specific
activity of 3VIgH enhancers. To assay expression more
precisely at the single-cell level, we decided to use GFP
as a reporter gene. The bright autofluorescence of GFP in
living cells provides a powerful strategy for measuring
expression in transfected cells and for assessing at the same
time by cell cytometry the lineage and the differentiation
stage of a given B cell. Moreover, similarly to the endog-
enous IgH locus, our transgene combines the intronic and
3Venhancers and a VH promoter, therefore allowing a coop-
eration between each element to ensure the correct spatial
and temporal expression of the GFP gene.
In a first set of experiments, we have assayed our trans-
gene by stable transfections in various cell lines. In associ-
ation with a GFP reporter gene, the 3VIgH regulatory region
combined with the EA element displayed some features of a
LCR, conferring a position-independent expression to the
GFP gene in pre-B cells and in mature B cells, but not a copy
number dependence. In a second set of experiments, trans-
genic mice bearing the EA-GFP-3VLCR transgene were
generated. These mice revealed that the EA-pVH-GFP re-
porter gene linked to the four elements of the 3V IgH
regulatory region exhibited in vivo a strictly B cell-specific
expression that closely reproduced the endogenous expres-
sion pattern of IgH genes. B220CD43+CD117+ cells rep-
resent an uncommitted lymphohematopoietic progenitor
population with IgH loci in germline configuration and able
to generate B cells, myeloid cells and T cells [19–21]. The
progressive loss of CD117 and CD43 antigens coincides
with the B-lineage commitment and the acquisition of the
B220 antigen by murine B cell precursors [22,23]. Flow
cytometry analysis clearly indicated that in EA-GFP-3VLCR
transgenic animals, B220CD43+CD117+ bone marrow
cells were all GFP while all GFP+ cells were B220+.
Among bone marrow B220+GFP+ cells, some belonged to
the pro-B and pre-B-I cell pool and were CD117+CD43+.
Later on, B220+ splenocytes bearing membrane IgM and
IgD also synthetized GFP, thus showing that the reporter
gene expression lasted from pro-B cells to mature B cells in
transgenic animals. The breeding of EA-GFP-3VLCR trans-
genic mice in a RAG / genetic background featuring a B
cell development arrest at the pro-B cell stage showed
expression of GFP at a very early stage during B cell
development (i.e., before pro-B cells undergo D to JH
recombination) and confirmed the early synergic interactionbetween EA and 3VLCR elements during B lymphocyte
maturation. In all analyzed transgenic animals, no GFP+
splenocytes expressed the Thy1,2 T cell marker and no GFP+
cells were found in thymus, thus confirming a stringent B
lymphocyte-specific GFP expression.
The main objective of this work was to determine the B
cell lineage developmental stage-specific expression of an
EA-GFP-3VLCR transgene. Indeed, the EA-LCR combina-
tion strictly restricted GFP expression to B lineage cells
whereas EA-driven transgene are sometimes expressed in T
lymphocytes or in skeletal muscles cells [7–9]. As previ-
ously noticed for other 3VIgH element-driven constructs [3],
a lack of copy number dependence appeared in our trans-
fected cell lines, and this issue was thus not worth further
checking in transgenic mice for which a limited number of
founders could be generated. By comparison to the herein
described enhancer combination, it is of importance to
mention that a similar construct including only EA and the
GFP gene was previously documented as being efficiently
expressed in stable B cell transfectants but totally silent in
transgenic mice [10]. It is also the case for a GFP-3VLCR
construct (unpublished data). Transgene methylation is
associated to the in vivo silencing of these two transgenes.
The same mechanism seems implicated for the in vivo
progressive silencing of the EA-GFP-3VLCR transgene that
occurs during ageing. DNA chemical modification by
methylation at the 5 carbon position of cytidine bases at
CG dinucleotides is known to be widely used in eucaryotic
cells in order to silence gene expression; unmethylated CG
are found in transcriptionally active chromatine [24], while
methylation is associated with transcriptional repression
[25]. Studies have shown that de novo methylation of
foreign DNA depends not only on the inserted nucleotide
sequence but also on the promoter/enhancer strength [26]. It
is thus tempting to speculate that the in vivo expression of
the EA-GFP-3VLCR transgene might be related to the strong
transcriptional synergy between EA and the 3VLCR [5,6],
which may temporary thwart transgene silencing.
In conclusion, in contrast with the non-stringent control
of EA-driven transgenes, the present construct combining
both 5Vand 3VIgH regulatory elements yields a high level of
expression that mimics the endogenous expression pattern
of the IgH genes and that is strictly confined to the B cell
lineage in a transgenic mouse model. This report also shows
that the combination of 3Vand 5V IgH regulatory elements
may constitute a potentially useful cassette in transgenes for
which a stringent B lineage-specific expression is required
all along the B cell maturation process.Acknowledgements
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